Skip to content

A Study of a Digital Program for Helping Young Adult Cancer Survivors Learn About Financial Issues Related to Healthcare

Making Cents of Medical Costs: A Digital Financial Toxicity Intervention for Adolescent and Young Adult Cancer Survivors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07780903
Enrollment
30
Registered
2026-08-24
Start date
2026-08-17
Completion date
2028-08-17
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

cancer, 26-316, Memorial Sloan Kettering Cancer Center

Brief summary

The purpose of this study is to find out whether the Making Cents of Medical Costs (MCMC) program is acceptable, appropriate, accessible, and practical (feasible) for young adult cancer survivors.

Interventions

BEHAVIORALMaking Cents of Medical Costs

Making Cents of Medical Costs (MCMC) is a three-session digital intervention to enhance cost-related health literacy, health insurance literacy, and financial capability.

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* English-speaking cancer survivors who are 18-39 years old * Diagnosed with cancer after age 14 * Has access to an Internet-enabled device * All disease sites and diagnosis are allowed; survivors must have completed active treatment

Exclusion criteria

* Received systemic therapy within the last 1 year

Design outcomes

Primary

MeasureTime frameDescription
Mean overall scores of Making Cents of Medical Costs (MCMC)12 monthsAssess participant-reported acceptability, appropriateness, accessibility, and feasibility of the Making Cents of Medical Costs (MCMC) intervention in a sample of 30 survivors of Adolescents and Young Adults (AYA) cancer. Acceptability, appropriateness, and feasibility will be defined as mean overall scores ≥3 (agree) within each domain for at least 70% of respondents.

Countries

United States

Contacts

CONTACTDanielle Friedman, MD
FriedmaD@mskcc.org212-639-7376
CONTACTChaya Moskowitz, PhD
moskowc1@MSKCC.ORG646-227-3607
PRINCIPAL_INVESTIGATORDanielle Friedman, MD

Memorial Sloan Kettering Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 25, 2026